A Retrospective Protocol Empowering Precision Research in Colorectal Cancer (ALFAOMEGA-RET
ALFAOMEGA-RETRÒ will be exploited to retrospectively collect clinical and imaging data and archival samples to be used for validation and correlative studies on markers discovered by cutting-edge translational projects within the AIRC5x1000 program "Insights into the evolving heterogeneity of colorectal cancer (CRC): f
| Condition(s) | Colorectal Cancer |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | ALFAOMEGA-RETRÒ will be exploited to retrospectively collect clinical and imaging data and archival samples to be used for validation and correlative studies on markers discovered by cutting-edge translational projects within the AIRC5x1000 program "Insights into the evolving heterogeneity of colorectal cancer (CRC): from mechanism to therapies" (an ongoing multi-institutional research program). |
| Who can participate | Inclusion Criteria: * Histologically-confirmed diagnosis of colorectal cancer (any stage). * Age \>18 years at the time of diagnosis. * Availability of clinically-annotated radio-imaging data and/or diagnostic Formalin-Fixed Paraffin Embedded (FFPE) blocks (surgical resections and/or tumor biopsies), or at least 10 slides (preferably 20). FFPE tissue blocks are always preferred to slides. * Verification that the patient could not be reached for informed consent in accordance with applicable national regulations. Exclusion Criteria: * if inclusion criteria are not met |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | IFOM ETS - The AIRC Institute of Molecular Oncology |
| Locations | Genova, GE, Italy; Milan, MI, Italy; Milan, MI, Italy; Milan, MI, Italy; Padua, PD, Italy; Pisa, Pisa, Italy (+7 more sites) |
| Start date | 2020-10-28 |
| NCT ID | NCT05101382 |
| Official listing | https://clinicaltrials.gov/study/NCT05101382 |